Advertisement

Index by author

November 01, 1986; Volume 239,Issue 2

A

  1. Abdel-Latif, A A

    1. Correlative studies on the effect of carbachol on myo-inositol trisphosphate accumulation, myosin light chain phosphorylation and contraction in sphincter smooth muscle of rabbit iris.
      P H Howe, R A Akhtar, S Naderi and A A Abdel-Latif
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 574-583;

  2. Abou-Donia, M B

    1. Relationship of tri-O-cresyl phosphate-induced delayed neurotoxicity to enhancement of in vitro phosphorylation of hen brain and spinal cord proteins.
      S E Patton, D M Lapadula and M B Abou-Donia
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 597-605;

  3. Akhtar, R A

    1. Correlative studies on the effect of carbachol on myo-inositol trisphosphate accumulation, myosin light chain phosphorylation and contraction in sphincter smooth muscle of rabbit iris.
      P H Howe, R A Akhtar, S Naderi and A A Abdel-Latif
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 574-583;

  4. Alho, H

    1. Intrinsic gamma aminobutyric acid receptors modulate the release of catecholamine from canine adrenal gland in situ.
      Y Kataoka, M Fujimoto, H Alho, A Guidotti, M Geffard, G D Kelly and I Hanbauer
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 584-590;

  5. Andresen, M C

    1. Do calcium antagonists act directly on calcium channels to alter baroreceptor function?
      D L Kunze, M C Andresen and L A Torres
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 303-310;

  6. Armstrong, D R

    1. Efficacy of baclofen and phenobarbital against the kainic acid limbic seizure-brain damage syndrome.
      B Ault, M Gruenthal, D R Armstrong and J V Nadler
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 612-617;

  7. Ault, B

    1. Efficacy of baclofen and phenobarbital against the kainic acid limbic seizure-brain damage syndrome.
      B Ault, M Gruenthal, D R Armstrong and J V Nadler
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 612-617;

B

  1. Baker, S

    1. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
      A P Roszkowski, G L Garay, S Baker, M Schuler and H Carter
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 382-389;

  2. Balster, R L

    1. Dependence on tetrahydrocannabinol in rhesus monkeys.
      P M Beardsley, R L Balster and L S Harris
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 311-319;

  3. Barrett, R J

    1. Myocardial and vascular actions of amiloride in spontaneously hypertensive rats.
      R J Barrett and S T Kau
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 365-374;

  4. Bayol, A

    1. Histamine contraction of isolated human airway muscle preparations: role of prostaglandins.
      I Haye-Legrand, J Cerrina, B Raffestin, C Labat, C Boullet, A Bayol, J Benveniste and C Brink
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 536-541;

  5. Beardsley, P M

    1. Dependence on tetrahydrocannabinol in rhesus monkeys.
      P M Beardsley, R L Balster and L S Harris
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 311-319;

  6. Benveniste, J

    1. Histamine contraction of isolated human airway muscle preparations: role of prostaglandins.
      I Haye-Legrand, J Cerrina, B Raffestin, C Labat, C Boullet, A Bayol, J Benveniste and C Brink
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 536-541;

  7. Bigelow, G E

    1. Human coffee drinking: reinforcing and physical dependence producing effects of caffeine.
      R R Griffiths, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 416-425;

  8. Biziere, K

    1. Evaluation of two anticonvulsant amino-pyridazine derivatives in the conflict test in rats.
      A Perio, J P Chambon, R Calassi, M Heaulme and K Biziere
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 542-547;

  9. Boullet, C

    1. Histamine contraction of isolated human airway muscle preparations: role of prostaglandins.
      I Haye-Legrand, J Cerrina, B Raffestin, C Labat, C Boullet, A Bayol, J Benveniste and C Brink
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 536-541;

  10. Bradbury, M W

    1. Effect of intravenous ferric or aluminum chloride on the uptake of 203Pb into brain and other soft tissues of rats.
      R Deane, S H Park and M W Bradbury
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 548-553;

  11. Brink, C

    1. Histamine contraction of isolated human airway muscle preparations: role of prostaglandins.
      I Haye-Legrand, J Cerrina, B Raffestin, C Labat, C Boullet, A Bayol, J Benveniste and C Brink
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 536-541;

  12. Byrne, A J

    1. Interaction between oral hydralazine and propranolol. II. Assessment of altered splanchnic blood flow as the determinant of altered presystemic extraction.
      H Corbett, C M Cahill, B Heinzow, P M Harrison, A J Byrne and A J McLean
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 517-521;

C

  1. Cahill, C M

    1. Interaction between oral hydralazine and propranolol. II. Assessment of altered splanchnic blood flow as the determinant of altered presystemic extraction.
      H Corbett, C M Cahill, B Heinzow, P M Harrison, A J Byrne and A J McLean
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 517-521;

  2. Calassi, R

    1. Evaluation of two anticonvulsant amino-pyridazine derivatives in the conflict test in rats.
      A Perio, J P Chambon, R Calassi, M Heaulme and K Biziere
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 542-547;

  3. Carter, H

    1. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
      A P Roszkowski, G L Garay, S Baker, M Schuler and H Carter
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 382-389;

  4. Cerrina, J

    1. Histamine contraction of isolated human airway muscle preparations: role of prostaglandins.
      I Haye-Legrand, J Cerrina, B Raffestin, C Labat, C Boullet, A Bayol, J Benveniste and C Brink
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 536-541;

  5. Chambon, J P

    1. Evaluation of two anticonvulsant amino-pyridazine derivatives in the conflict test in rats.
      A Perio, J P Chambon, R Calassi, M Heaulme and K Biziere
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 542-547;

  6. Chen, Y F

    1. Mechanism of the depressor action of LY171555, a selective dopamine D2 receptor agonist, in the anesthetized rat.
      S Nagahama, Y F Chen, M D Lindheimer and S Oparil
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 426-432;

  7. Chiari, M C

    1. Presynaptic inhibitory muscarinic receptors modulating [3H] acetylcholine release in the rat urinary bladder.
      G D'Agostino, H Kilbinger, M C Chiari and E Grana
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 522-528;

  8. Collins, A C

    1. Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains.
      M J Marks, J A Stitzel and A C Collins
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 358-364;

  9. Corbett, H

    1. Interaction between oral hydralazine and propranolol. II. Assessment of altered splanchnic blood flow as the determinant of altered presystemic extraction.
      H Corbett, C M Cahill, B Heinzow, P M Harrison, A J Byrne and A J McLean
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 517-521;

  10. Crabbe, J C

    1. Sensitivity and tolerance to ethanol in mice bred to be genetically prone or resistant to ethanol withdrawal seizures.
      J C Crabbe and A Kosobud
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 327-333;

D

  1. D'Agostino, G

    1. Presynaptic inhibitory muscarinic receptors modulating [3H] acetylcholine release in the rat urinary bladder.
      G D'Agostino, H Kilbinger, M C Chiari and E Grana
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 522-528;

  2. Deane, R

    1. Effect of intravenous ferric or aluminum chloride on the uptake of 203Pb into brain and other soft tissues of rats.
      R Deane, S H Park and M W Bradbury
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 548-553;

  3. DeGott, C

    1. Pre- or post-treatment with methoxsalen prevents the hepatotoxicity of acetaminophen in mice.
      P Letteron, V Descatoire, D Larrey, C DeGott, M Tinel, J Geneve and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 559-567;

  4. Descatoire, V

    1. Pre- or post-treatment with methoxsalen prevents the hepatotoxicity of acetaminophen in mice.
      P Letteron, V Descatoire, D Larrey, C DeGott, M Tinel, J Geneve and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 559-567;

  5. Dewey, W L

    1. A characterization of the antinociception produced by intracerebroventricular injection of 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate in mice.
      S P Welch and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 320-326;

  6. DiMicco, J A

    1. Beta adrenoceptor modulation of the generation of murine cytotoxic T lymphocytes in vitro.
      S M Hatfield, B H Petersen and J A DiMicco
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 460-466;

  7. Dungan, K W

    1. In vitro effects of beta adrenoceptor agonists and antagonists on the rat ovarian suspensory ligament.
      H C Stanton and K W Dungan
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 591-596;

  8. Dwoskin, L P

    1. Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors.
      L P Dwoskin and N R Zahniser
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 442-453;

E

  1. Elverdin, J C

    1. Sympathetic and parasympathetic nerves regulate postsynaptic alpha-2 adrenoceptor in salivary glands.
      M D Kaniucki, J C Elverdin, M A Luchelli-Fortis, C J Perec and F J Stefano
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 488-493;

  2. Evans, D C

    1. Actions of nizatidine on the rat uterus, dog stomach and experimentally induced gastric lesions.
      T M Lin, D C Evans, M W Warrick and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 400-405;
    2. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs.
      T M Lin, D C Evans, M W Warrick and R P Pioch
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 406-410;

F

  1. Fujimoto, M

    1. Intrinsic gamma aminobutyric acid receptors modulate the release of catecholamine from canine adrenal gland in situ.
      Y Kataoka, M Fujimoto, H Alho, A Guidotti, M Geffard, G D Kelly and I Hanbauer
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 584-590;

  2. Fujiwara, M

    1. Effects of neurokinin A, substance P and electrical stimulation on the rabbit iris sphincter muscle.
      N Ueda, I Muramatsu, T Taniguchi, S Nakanishi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 494-499;
    2. Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei.
      S Narumiya, K Ohno, M Fujiwara and M Fukushima
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 506-511;

  3. Fukushima, M

    1. Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition.
      S Narumiya and M Fukushima
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 500-505;
    2. Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei.
      S Narumiya, K Ohno, M Fujiwara and M Fukushima
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 506-511;

  4. Fuller, R W

    1. Central serotonin agonist actions of LY 165163, 1-(m-trifluoromethylphenyl)-4-(p-aminophenylethyl) piperazine, in rats.
      R W Fuller, H D Snoddy and B B Molloy
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 454-459;

  5. Furukawa, T

    1. Release of acetylcholine mediated by cholecystokinin receptor from the guinea pig sphincter of Oddi.
      T Harada, T Katsuragi and T Furukawa
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 554-558;

G

  1. Garay, G L

    1. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
      A P Roszkowski, G L Garay, S Baker, M Schuler and H Carter
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 382-389;

  2. Garty, M

    1. Tolerance to morphine effects on renal disposition of xenobiotics in mice.
      M Garty and A Hurwitz
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 346-350;

  3. Geffard, M

    1. Intrinsic gamma aminobutyric acid receptors modulate the release of catecholamine from canine adrenal gland in situ.
      Y Kataoka, M Fujimoto, H Alho, A Guidotti, M Geffard, G D Kelly and I Hanbauer
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 584-590;

  4. Geneve, J

    1. Pre- or post-treatment with methoxsalen prevents the hepatotoxicity of acetaminophen in mice.
      P Letteron, V Descatoire, D Larrey, C DeGott, M Tinel, J Geneve and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 559-567;

  5. Goldberg, S R

    1. Effects of ethylketazocine and morphine on schedule-controlled behavior in pigeons and squirrel monkeys.
      J L Katz and S R Goldberg
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 433-441;

  6. Grana, E

    1. Presynaptic inhibitory muscarinic receptors modulating [3H] acetylcholine release in the rat urinary bladder.
      G D'Agostino, H Kilbinger, M C Chiari and E Grana
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 522-528;

  7. Griffiths, R R

    1. Human coffee drinking: reinforcing and physical dependence producing effects of caffeine.
      R R Griffiths, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 416-425;

  8. Gruenthal, M

    1. Efficacy of baclofen and phenobarbital against the kainic acid limbic seizure-brain damage syndrome.
      B Ault, M Gruenthal, D R Armstrong and J V Nadler
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 612-617;

  9. Guidotti, A

    1. Intrinsic gamma aminobutyric acid receptors modulate the release of catecholamine from canine adrenal gland in situ.
      Y Kataoka, M Fujimoto, H Alho, A Guidotti, M Geffard, G D Kelly and I Hanbauer
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 584-590;

H

  1. Haass, M

    1. Interactions of atrial natriuretic peptide with the sympathetic and endocrine systems in the pithed rat.
      Z Zukowska-Grojec, M Haass, I J Kopin and N Zamir
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 480-487;

  2. Hanbauer, I

    1. Intrinsic gamma aminobutyric acid receptors modulate the release of catecholamine from canine adrenal gland in situ.
      Y Kataoka, M Fujimoto, H Alho, A Guidotti, M Geffard, G D Kelly and I Hanbauer
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 584-590;

  3. Harada, T

    1. Release of acetylcholine mediated by cholecystokinin receptor from the guinea pig sphincter of Oddi.
      T Harada, T Katsuragi and T Furukawa
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 554-558;

  4. Harris, L S

    1. Dependence on tetrahydrocannabinol in rhesus monkeys.
      P M Beardsley, R L Balster and L S Harris
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 311-319;

  5. Harrison, P M

    1. Interaction between oral hydralazine and propranolol. II. Assessment of altered splanchnic blood flow as the determinant of altered presystemic extraction.
      H Corbett, C M Cahill, B Heinzow, P M Harrison, A J Byrne and A J McLean
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 517-521;

  6. Hassid, A

    1. Increase of cyclic AMP concentrations in cultured vascular smooth muscle cells by vasoactive peptide hormones. Role of endogenous prostaglandins.
      A Hassid
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 334-339;

  7. Hatfield, S M

    1. Beta adrenoceptor modulation of the generation of murine cytotoxic T lymphocytes in vitro.
      S M Hatfield, B H Petersen and J A DiMicco
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 460-466;

  8. Haye-Legrand, I

    1. Histamine contraction of isolated human airway muscle preparations: role of prostaglandins.
      I Haye-Legrand, J Cerrina, B Raffestin, C Labat, C Boullet, A Bayol, J Benveniste and C Brink
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 536-541;

  9. Hayes, J S

    1. Molecular basis for the in vitro and in vivo cardiotonic activities of AR-L100.
      J S Hayes, V L Wyss, H C Wilson, D W Robertson and R F Kauffman
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 375-381;

  10. Heaulme, M

    1. Evaluation of two anticonvulsant amino-pyridazine derivatives in the conflict test in rats.
      A Perio, J P Chambon, R Calassi, M Heaulme and K Biziere
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 542-547;

  11. Heinzow, B

    1. Interaction between oral hydralazine and propranolol. II. Assessment of altered splanchnic blood flow as the determinant of altered presystemic extraction.
      H Corbett, C M Cahill, B Heinzow, P M Harrison, A J Byrne and A J McLean
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 517-521;

  12. Hoffman, B B

    1. Age-related decrease in beta adrenergic receptor-mediated vascular smooth muscle relaxation.
      G Tsujimoto, C H Lee and B B Hoffman
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 411-415;

  13. Honda, K

    1. Alpha-1 adrenoceptor antagonist effects of the optical isomers of YM-12617 in rabbit lower urinary tract and prostate.
      K Honda and C Nakagawa
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 512-516;

  14. Howe, P H

    1. Correlative studies on the effect of carbachol on myo-inositol trisphosphate accumulation, myosin light chain phosphorylation and contraction in sphincter smooth muscle of rabbit iris.
      P H Howe, R A Akhtar, S Naderi and A A Abdel-Latif
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 574-583;

  15. Hurwitz, A

    1. Tolerance to morphine effects on renal disposition of xenobiotics in mice.
      M Garty and A Hurwitz
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 346-350;

  16. Hyman, A L

    1. Analysis of airway responses to A23187 in the cat.
      T Kriseman, D C Underwood, A L Hyman and P J Kadowitz
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 395-399;

K

  1. Kadowitz, P J

    1. Analysis of airway responses to A23187 in the cat.
      T Kriseman, D C Underwood, A L Hyman and P J Kadowitz
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 395-399;

  2. Kaniucki, M D

    1. Sympathetic and parasympathetic nerves regulate postsynaptic alpha-2 adrenoceptor in salivary glands.
      M D Kaniucki, J C Elverdin, M A Luchelli-Fortis, C J Perec and F J Stefano
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 488-493;

  3. Kataoka, Y

    1. Intrinsic gamma aminobutyric acid receptors modulate the release of catecholamine from canine adrenal gland in situ.
      Y Kataoka, M Fujimoto, H Alho, A Guidotti, M Geffard, G D Kelly and I Hanbauer
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 584-590;

  4. Katsube, N

    1. Atriopeptin turnover: quantitative relationship between in vivo changes in plasma levels and atrial content.
      N Katsube, D Schwartz and P Needleman
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 474-479;

  5. Katsuragi, T

    1. Release of acetylcholine mediated by cholecystokinin receptor from the guinea pig sphincter of Oddi.
      T Harada, T Katsuragi and T Furukawa
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 554-558;

  6. Katz, J L

    1. Effects of ethylketazocine and morphine on schedule-controlled behavior in pigeons and squirrel monkeys.
      J L Katz and S R Goldberg
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 433-441;

  7. Kau, S T

    1. Myocardial and vascular actions of amiloride in spontaneously hypertensive rats.
      R J Barrett and S T Kau
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 365-374;

  8. Kauffman, R F

    1. Molecular basis for the in vitro and in vivo cardiotonic activities of AR-L100.
      J S Hayes, V L Wyss, H C Wilson, D W Robertson and R F Kauffman
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 375-381;

  9. Kelly, G D

    1. Intrinsic gamma aminobutyric acid receptors modulate the release of catecholamine from canine adrenal gland in situ.
      Y Kataoka, M Fujimoto, H Alho, A Guidotti, M Geffard, G D Kelly and I Hanbauer
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 584-590;

  10. Kilbinger, H

    1. Presynaptic inhibitory muscarinic receptors modulating [3H] acetylcholine release in the rat urinary bladder.
      G D'Agostino, H Kilbinger, M C Chiari and E Grana
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 522-528;

  11. Kopin, I J

    1. Interactions of atrial natriuretic peptide with the sympathetic and endocrine systems in the pithed rat.
      Z Zukowska-Grojec, M Haass, I J Kopin and N Zamir
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 480-487;

  12. Kosobud, A

    1. Sensitivity and tolerance to ethanol in mice bred to be genetically prone or resistant to ethanol withdrawal seizures.
      J C Crabbe and A Kosobud
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 327-333;

  13. Kot, P A

    1. Role of the vascular endothelium in the contractile response to prostacyclin in the isolated rat aorta.
      J Van Dam, Y T Maddox, P W Ramwell and P A Kot
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 390-394;

  14. Kreulen, D L

    1. Action of cholecystokinin octapeptide and CCK-related peptides on neurons in inferior mesenteric ganglion of guinea pig.
      M A Schumann and D L Kreulen
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 618-625;

  15. Kriseman, T

    1. Analysis of airway responses to A23187 in the cat.
      T Kriseman, D C Underwood, A L Hyman and P J Kadowitz
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 395-399;

  16. Kunze, D L

    1. Do calcium antagonists act directly on calcium channels to alter baroreceptor function?
      D L Kunze, M C Andresen and L A Torres
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 303-310;

L

  1. Labat, C

    1. Histamine contraction of isolated human airway muscle preparations: role of prostaglandins.
      I Haye-Legrand, J Cerrina, B Raffestin, C Labat, C Boullet, A Bayol, J Benveniste and C Brink
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 536-541;

  2. Lapadula, D M

    1. Relationship of tri-O-cresyl phosphate-induced delayed neurotoxicity to enhancement of in vitro phosphorylation of hen brain and spinal cord proteins.
      S E Patton, D M Lapadula and M B Abou-Donia
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 597-605;

  3. Larrey, D

    1. Pre- or post-treatment with methoxsalen prevents the hepatotoxicity of acetaminophen in mice.
      P Letteron, V Descatoire, D Larrey, C DeGott, M Tinel, J Geneve and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 559-567;

  4. Lee, C H

    1. Age-related decrease in beta adrenergic receptor-mediated vascular smooth muscle relaxation.
      G Tsujimoto, C H Lee and B B Hoffman
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 411-415;

  5. Lee, E K

    1. Effects of anticonvulsant drugs on substantia nigra pars reticulata neurons.
      B L Waszczak, E K Lee and J R Walters
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 606-611;

  6. Letteron, P

    1. Pre- or post-treatment with methoxsalen prevents the hepatotoxicity of acetaminophen in mice.
      P Letteron, V Descatoire, D Larrey, C DeGott, M Tinel, J Geneve and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 559-567;

  7. Liebson, I A

    1. Human coffee drinking: reinforcing and physical dependence producing effects of caffeine.
      R R Griffiths, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 416-425;

  8. Lin, T M

    1. Actions of nizatidine on the rat uterus, dog stomach and experimentally induced gastric lesions.
      T M Lin, D C Evans, M W Warrick and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 400-405;
    2. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs.
      T M Lin, D C Evans, M W Warrick and R P Pioch
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 406-410;

  9. Lindheimer, M D

    1. Mechanism of the depressor action of LY171555, a selective dopamine D2 receptor agonist, in the anesthetized rat.
      S Nagahama, Y F Chen, M D Lindheimer and S Oparil
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 426-432;

  10. Liu-Chen, L Y

    1. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
      S W Tam and L Y Liu-Chen
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 351-357;

  11. Lucchesi, B R

    1. The effects of calcium entry blockade on the vulnerability of infarcted canine myocardium toward ventricular fibrillation.
      J J Lynch, D G Montgomery and B R Lucchesi
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 340-345;

  12. Luchelli-Fortis, M A

    1. Sympathetic and parasympathetic nerves regulate postsynaptic alpha-2 adrenoceptor in salivary glands.
      M D Kaniucki, J C Elverdin, M A Luchelli-Fortis, C J Perec and F J Stefano
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 488-493;

  13. Lynch, J J

    1. The effects of calcium entry blockade on the vulnerability of infarcted canine myocardium toward ventricular fibrillation.
      J J Lynch, D G Montgomery and B R Lucchesi
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 340-345;

M

  1. Maddox, Y T

    1. Role of the vascular endothelium in the contractile response to prostacyclin in the isolated rat aorta.
      J Van Dam, Y T Maddox, P W Ramwell and P A Kot
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 390-394;

  2. Marks, M J

    1. Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains.
      M J Marks, J A Stitzel and A C Collins
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 358-364;

  3. McLean, A J

    1. Interaction between oral hydralazine and propranolol. II. Assessment of altered splanchnic blood flow as the determinant of altered presystemic extraction.
      H Corbett, C M Cahill, B Heinzow, P M Harrison, A J Byrne and A J McLean
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 517-521;

  4. Molloy, B B

    1. Central serotonin agonist actions of LY 165163, 1-(m-trifluoromethylphenyl)-4-(p-aminophenylethyl) piperazine, in rats.
      R W Fuller, H D Snoddy and B B Molloy
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 454-459;

  5. Montgomery, D G

    1. The effects of calcium entry blockade on the vulnerability of infarcted canine myocardium toward ventricular fibrillation.
      J J Lynch, D G Montgomery and B R Lucchesi
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 340-345;

  6. Muramatsu, I

    1. Effects of neurokinin A, substance P and electrical stimulation on the rabbit iris sphincter muscle.
      N Ueda, I Muramatsu, T Taniguchi, S Nakanishi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 494-499;

N

  1. Naderi, S

    1. Correlative studies on the effect of carbachol on myo-inositol trisphosphate accumulation, myosin light chain phosphorylation and contraction in sphincter smooth muscle of rabbit iris.
      P H Howe, R A Akhtar, S Naderi and A A Abdel-Latif
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 574-583;

  2. Nadler, J V

    1. Efficacy of baclofen and phenobarbital against the kainic acid limbic seizure-brain damage syndrome.
      B Ault, M Gruenthal, D R Armstrong and J V Nadler
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 612-617;

  3. Nagahama, S

    1. Mechanism of the depressor action of LY171555, a selective dopamine D2 receptor agonist, in the anesthetized rat.
      S Nagahama, Y F Chen, M D Lindheimer and S Oparil
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 426-432;

  4. Nakagawa, C

    1. Alpha-1 adrenoceptor antagonist effects of the optical isomers of YM-12617 in rabbit lower urinary tract and prostate.
      K Honda and C Nakagawa
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 512-516;

  5. Nakanishi, S

    1. Effects of neurokinin A, substance P and electrical stimulation on the rabbit iris sphincter muscle.
      N Ueda, I Muramatsu, T Taniguchi, S Nakanishi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 494-499;

  6. Narumiya, S

    1. Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition.
      S Narumiya and M Fukushima
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 500-505;
    2. Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei.
      S Narumiya, K Ohno, M Fujiwara and M Fukushima
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 506-511;

  7. Needleman, P

    1. Atriopeptin turnover: quantitative relationship between in vivo changes in plasma levels and atrial content.
      N Katsube, D Schwartz and P Needleman
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 474-479;

  8. Noda, H

    1. Biliary excretion of organic anions in diabetic rats.
      J B Watkins and H Noda
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 467-473;

O

  1. Ohno, K

    1. Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei.
      S Narumiya, K Ohno, M Fujiwara and M Fukushima
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 506-511;

  2. Oparil, S

    1. Mechanism of the depressor action of LY171555, a selective dopamine D2 receptor agonist, in the anesthetized rat.
      S Nagahama, Y F Chen, M D Lindheimer and S Oparil
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 426-432;

P

  1. Park, S H

    1. Effect of intravenous ferric or aluminum chloride on the uptake of 203Pb into brain and other soft tissues of rats.
      R Deane, S H Park and M W Bradbury
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 548-553;

  2. Patton, S E

    1. Relationship of tri-O-cresyl phosphate-induced delayed neurotoxicity to enhancement of in vitro phosphorylation of hen brain and spinal cord proteins.
      S E Patton, D M Lapadula and M B Abou-Donia
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 597-605;

  3. Perec, C J

    1. Sympathetic and parasympathetic nerves regulate postsynaptic alpha-2 adrenoceptor in salivary glands.
      M D Kaniucki, J C Elverdin, M A Luchelli-Fortis, C J Perec and F J Stefano
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 488-493;

  4. Perio, A

    1. Evaluation of two anticonvulsant amino-pyridazine derivatives in the conflict test in rats.
      A Perio, J P Chambon, R Calassi, M Heaulme and K Biziere
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 542-547;

  5. Pessayre, D

    1. Pre- or post-treatment with methoxsalen prevents the hepatotoxicity of acetaminophen in mice.
      P Letteron, V Descatoire, D Larrey, C DeGott, M Tinel, J Geneve and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 559-567;

  6. Petersen, B H

    1. Beta adrenoceptor modulation of the generation of murine cytotoxic T lymphocytes in vitro.
      S M Hatfield, B H Petersen and J A DiMicco
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 460-466;

  7. Pioch, R P

    1. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs.
      T M Lin, D C Evans, M W Warrick and R P Pioch
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 406-410;

R

  1. Raffestin, B

    1. Histamine contraction of isolated human airway muscle preparations: role of prostaglandins.
      I Haye-Legrand, J Cerrina, B Raffestin, C Labat, C Boullet, A Bayol, J Benveniste and C Brink
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 536-541;

  2. Ramwell, P W

    1. Role of the vascular endothelium in the contractile response to prostacyclin in the isolated rat aorta.
      J Van Dam, Y T Maddox, P W Ramwell and P A Kot
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 390-394;

  3. Robertson, D W

    1. Molecular basis for the in vitro and in vivo cardiotonic activities of AR-L100.
      J S Hayes, V L Wyss, H C Wilson, D W Robertson and R F Kauffman
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 375-381;

  4. Roszkowski, A P

    1. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
      A P Roszkowski, G L Garay, S Baker, M Schuler and H Carter
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 382-389;

  5. Ruffolo, R R

    1. Actions of nizatidine on the rat uterus, dog stomach and experimentally induced gastric lesions.
      T M Lin, D C Evans, M W Warrick and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 400-405;

S

  1. Schuler, M

    1. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
      A P Roszkowski, G L Garay, S Baker, M Schuler and H Carter
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 382-389;

  2. Schumann, M A

    1. Action of cholecystokinin octapeptide and CCK-related peptides on neurons in inferior mesenteric ganglion of guinea pig.
      M A Schumann and D L Kreulen
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 618-625;

  3. Schwartz, D

    1. Atriopeptin turnover: quantitative relationship between in vivo changes in plasma levels and atrial content.
      N Katsube, D Schwartz and P Needleman
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 474-479;

  4. Snoddy, H D

    1. Central serotonin agonist actions of LY 165163, 1-(m-trifluoromethylphenyl)-4-(p-aminophenylethyl) piperazine, in rats.
      R W Fuller, H D Snoddy and B B Molloy
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 454-459;

  5. Stanton, H C

    1. In vitro effects of beta adrenoceptor agonists and antagonists on the rat ovarian suspensory ligament.
      H C Stanton and K W Dungan
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 591-596;

  6. Stefano, F J

    1. Sympathetic and parasympathetic nerves regulate postsynaptic alpha-2 adrenoceptor in salivary glands.
      M D Kaniucki, J C Elverdin, M A Luchelli-Fortis, C J Perec and F J Stefano
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 488-493;

  7. Stitzel, J A

    1. Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains.
      M J Marks, J A Stitzel and A C Collins
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 358-364;

T

  1. Tam, S W

    1. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
      S W Tam and L Y Liu-Chen
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 351-357;

  2. Taniguchi, T

    1. Effects of neurokinin A, substance P and electrical stimulation on the rabbit iris sphincter muscle.
      N Ueda, I Muramatsu, T Taniguchi, S Nakanishi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 494-499;

  3. Tinel, M

    1. Pre- or post-treatment with methoxsalen prevents the hepatotoxicity of acetaminophen in mice.
      P Letteron, V Descatoire, D Larrey, C DeGott, M Tinel, J Geneve and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 559-567;

  4. Toda, N

    1. Mechanisms of histamine-induced relaxation in isolated monkey and dog coronary arteries.
      N Toda
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 529-535;

  5. Torres, L A

    1. Do calcium antagonists act directly on calcium channels to alter baroreceptor function?
      D L Kunze, M C Andresen and L A Torres
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 303-310;

  6. Tsujimoto, G

    1. Age-related decrease in beta adrenergic receptor-mediated vascular smooth muscle relaxation.
      G Tsujimoto, C H Lee and B B Hoffman
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 411-415;

U

  1. Ueda, N

    1. Effects of neurokinin A, substance P and electrical stimulation on the rabbit iris sphincter muscle.
      N Ueda, I Muramatsu, T Taniguchi, S Nakanishi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 494-499;

  2. Underwood, D C

    1. Analysis of airway responses to A23187 in the cat.
      T Kriseman, D C Underwood, A L Hyman and P J Kadowitz
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 395-399;

V

  1. Van Dam, J

    1. Role of the vascular endothelium in the contractile response to prostacyclin in the isolated rat aorta.
      J Van Dam, Y T Maddox, P W Ramwell and P A Kot
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 390-394;

W

  1. Walters, J R

    1. Effects of anticonvulsant drugs on substantia nigra pars reticulata neurons.
      B L Waszczak, E K Lee and J R Walters
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 606-611;

  2. Warrick, M W

    1. Actions of nizatidine on the rat uterus, dog stomach and experimentally induced gastric lesions.
      T M Lin, D C Evans, M W Warrick and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 400-405;
    2. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs.
      T M Lin, D C Evans, M W Warrick and R P Pioch
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 406-410;

  3. Waszczak, B L

    1. Effects of anticonvulsant drugs on substantia nigra pars reticulata neurons.
      B L Waszczak, E K Lee and J R Walters
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 606-611;

  4. Watkins, J B

    1. Biliary excretion of organic anions in diabetic rats.
      J B Watkins and H Noda
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 467-473;

  5. Welch, S P

    1. A characterization of the antinociception produced by intracerebroventricular injection of 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate in mice.
      S P Welch and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 320-326;

  6. Wilson, H C

    1. Molecular basis for the in vitro and in vivo cardiotonic activities of AR-L100.
      J S Hayes, V L Wyss, H C Wilson, D W Robertson and R F Kauffman
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 375-381;

  7. Wojcik, W J

    1. Gamma aminobutyric acid B receptor-mediated inhibition of adenylate cyclase in cultured cerebellar granule cells: blockade by islet-activating protein.
      J Xu and W J Wojcik
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 568-573;

  8. Wyss, V L

    1. Molecular basis for the in vitro and in vivo cardiotonic activities of AR-L100.
      J S Hayes, V L Wyss, H C Wilson, D W Robertson and R F Kauffman
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 375-381;

X

  1. Xu, J

    1. Gamma aminobutyric acid B receptor-mediated inhibition of adenylate cyclase in cultured cerebellar granule cells: blockade by islet-activating protein.
      J Xu and W J Wojcik
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 568-573;

Z

  1. Zahniser, N R

    1. Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors.
      L P Dwoskin and N R Zahniser
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 442-453;

  2. Zamir, N

    1. Interactions of atrial natriuretic peptide with the sympathetic and endocrine systems in the pithed rat.
      Z Zukowska-Grojec, M Haass, I J Kopin and N Zamir
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 480-487;

  3. Zukowska-Grojec, Z

    1. Interactions of atrial natriuretic peptide with the sympathetic and endocrine systems in the pithed rat.
      Z Zukowska-Grojec, M Haass, I J Kopin and N Zamir
      Journal of Pharmacology and Experimental Therapeutics November 1986, 239 (2) 480-487;
Back to top

In this issue

Advertisement